Selective cyclo-oxygenase-2 inhibitors impair adipocyte differentiation through inhibition of the clonal expansion

Lluis Fajas1, Stephanie Miard, Michael R Briggs

  • 1Institut de Génétique et de Biologie Moléculaire et Cellulaire, CNRS/INSERM/ULP, B. P. 163, F-67404 Illkirch cedex, C.U. de Strasbourg, France.

Insights

Selective cyclo-oxygenase-2 (COX-2) inhibitors hinder fat cell differentiation by blocking cell cycle reentry. This finding suggests COX-2 modulation may offer new strategies for managing obesity and metabolic diseases.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Metabolic Disease Research

Background:

  • Selective cyclo-oxygenase-2 (COX-2) inhibitors are nonsteroidal anti-inflammatory drugs (NSAIDs).
  • These drugs are commonly used for managing inflammatory conditions.
  • The role of COX-2 in metabolic processes like adipogenesis is not fully understood.

Purpose of the Study:

  • To investigate the effect of COX-2 inhibition on adipocyte differentiation.
  • To determine the specific phase of adipogenesis affected by COX-2.
  • To elucidate the molecular mechanisms underlying COX-2's role in adipogenesis.

Main Methods:

  • Utilized selective COX-2 inhibitors in cell culture models.
  • Assessed adipocyte differentiation markers and cell cycle progression.
  • Analyzed the involvement of prostaglandin pathways (e.g., PGE2, PGD2).

Main Results:

  • COX-2 inhibition significantly impaired adipocyte differentiation.
  • The inhibition occurred during the early clonal expansion phase of adipogenesis.
  • COX-2 blockade limited cell cycle reentry, a prerequisite for differentiation.
  • This effect was independent of prostaglandin J2 but dependent on proliferative prostaglandins like prostaglandin E2.

Conclusions:

  • COX-2 plays a critical role in regulating adipocyte differentiation.
  • Inhibition of COX-2 disrupts the cell cycle progression necessary for adipogenesis.
  • Modulating COX-2 activity presents a potential therapeutic avenue for obesity and related metabolic disorders.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Cycloaddition Reactions: MO Requirements for Thermal Activation01:16

Cycloaddition Reactions: MO Requirements for Thermal Activation

Thermal cycloadditions are reactions where the source of activation energy needed to initiate the reaction is provided in the form of heat. A typical example of a thermally-allowed cycloaddition is the Diels–Alder reaction, which is a [4 + 2] cycloaddition. In contrast, a [2 + 2] cycloaddition is thermally forbidden.
Cycloaddition Reactions: Overview01:16

Cycloaddition Reactions: Overview

Cycloadditions are one of the most valuable and effective synthesis routes to form cyclic compounds. These are concerted pericyclic reactions between two unsaturated compounds resulting in a cyclic product with two new σ bonds formed at the expense of π bonds. The [4 + 2] cycloaddition, known as the Diels–Alder reaction, is the most common. The other example is a [2 + 2] cycloaddition.
Oxidation of Alkenes: Anti Dihydroxylation with Peroxy Acids02:04

Oxidation of Alkenes: Anti Dihydroxylation with Peroxy Acids

Diols are compounds with two hydroxyl groups. In addition to syn dihydroxylation, diols can also be synthesized through the process of anti dihydroxylation. The process involves treating an alkene with a peroxycarboxylic acid to form an epoxide. Epoxides are highly strained three-membered rings with oxygen and two carbons occupying the corners of an equilateral triangle. This step is followed by ring-opening of the epoxide in the presence of an aqueous acid to give a trans diol.